Inhibitory effects of Re-188 labeled Herceptin on prostate cancer cell survival: a possible radioimmunotherapy to prostate carcinoma
博士 === 國立中興大學 === 生命科學系所 === 101 === Background: Advanced or metastatic prostate cancers tend to turn into castration-resistant cancers after hormonal therapy. Most of these cases are characterized by elevated HER2 expression and have poor prognosis. Herceptin (Trastuzumab), a humanized anti-HER2 mo...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/n48xpz |